The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera

被引：44

作者：

Cario, H ^{[1
]}

Goerttler, PS

Steimle, C

Levine, RL

Pahl, HL

机构：

[1] Univ Hosp Ulm, Dept Paediat, Ulm, Germany

[2] Univ Hosp Freiburg, Dept Expt Anaesthesiol, Freiburg, Germany

[3] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2005年 / 130卷 / 05期

关键词：

myeloproliferative disorders;

D O I：

10.1111/j.1365-2141.2005.05683.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：800 / 801

页数：2

共 6 条

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[2] Familial polycythemia vera with Budd-Chiari syndrome in childhood [J].

Cario, H ;

Pahl, HL ;

Schwarz, K ;

Galm, C ;

Hoffmann, M ;

Burdelski, M ;

Kohne, E ;

Debatin, KM .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 123 (02) :346-352

[3] A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].

James, C ;

Ugo, V ;

Le Couédic, JP ;

Staerk, J ;

Delhommeau, F ;

Lacout, C ;

Garçon, L ;

Raslova, H ;

Berger, R ;

Bennaceur-Griscelli, A ;

Villeval, JL ;

Constantinescu, SN ;

Casadevall, N ;

Vainchenker, W .

NATURE, 2005, 434 (7037) :1144-1148

[4] Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease [J].

Kralovics, R ;

Stockton, DW ;

Prchal, JT .

BLOOD, 2003, 102 (10) :3793-3796

[5] A gain-of-function mutation of JAK2 in myeloproliferative disorders [J].

Kralovics, R ;

Passamonti, F ;

Buser, AS ;

Teo, S ;

Tiedt, R ;

Passweg, JR ;

Tichelli, A ;

Cazzola, M ;

Skoda, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1779-1790

[6] Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis [J].

Levine, RL ;

Wadleigh, M ;

Cools, J ;

Ebert, BL ;

Wernig, G ;

Huntly, BJP ;

Boggon, TJ ;

Wlodarska, L ;

Clark, JJ ;

Moore, S ;

Adelsperger, J ;

Koo, S ;

Lee, JC ;

Gabriel, S ;

Mercher, T ;

D'Andrea, A ;

Fröhling, S ;

Döhner, K ;

Marynen, P ;

Vandenberghe, P ;

Mesa, RA ;

Tefferi, A ;

Griffin, JD ;

Eck, MJ ;

Sellers, WR ;

Meyerson, M ;

Golub, TR ;

Lee, SJ ;

Gilliland, DG .

CANCER CELL, 2005, 7 (04) :387-397

← 1 →